4,496,744 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) PRE-FUNDED WARRANTS TO PURCHASE 12,895,256 SHARES OF COMMON STOCK PRELUDE THERAPEUTICS INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • May 19th, 2023 • Prelude Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 19th, 2023 Company Industry Jurisdiction